proteins, transcriptional synergy, or both (for reviews see Maniatis et al., 1987; McKnight and Yamamoto, 1992; Ptashne, 1992; Tjian and Maniatis, 1994 ; see also Robertson et al., 1995) . these observations strongly support the hypothesis that the specificity of the inducible activation of the lFNf3 gene promoter requires the assembly of an enhanceosome (a term first used by Bazett-Jones et al. [1994] ).
Results
The Number and Types of Regulatory Elements Present in the IFNB Gene Enhancer Determine the Specificity and Level of Induction The combinatorial nature of the lFNf3 gene enhancer is best illustrated by the observation that mutations that inactivate any one of the PRDs in the context of the lFNf3 promoter result in a dramatic decrease in the level of virus induction. Moreover, a single copy of any PRD is inactive, but artificial enhancers can be created by multimerization of these elements (for review see Maniatis et al., 1992) . Synthetic promoters containing multiple copies of individual PRDs are not only inducible by virus; they respond to other inducers as well (Fan and Maniatis, 1989; Leblanc et al., 1990; Duet al., 1993; Thanos and Maniatis, 1995b) . For example, multiple copies of PRDII are activated by virus and by numerous other inducers of NF-KB. However, the intact enhancer responds only to virus infection. This point is illustrated in Figure 1 , where synthetic reporters containing multiple copies of PRDIV, PRDIII-I, and PRDII were transfected into mouse L929 cells, which were then challenged with various inducers. The synthetic promoter containing multiple copies of PRDIV is inducible by virus and is slightly more inducible by CAMP. Similarly, a promoter containing multiple copies of the PRDIII-I element is inducible by both virus and IFNy (M. Wathelet and T. M., unpublished data). Finally, a reporter containing multiple copies of PRDII is inducible by tumor necrosis factor a (TNFa) and virus infection. Thus, all of the synthetic enhancers respond to virus infection, but they also respond to other inducers that activate transcription factors known to bind to these sites.
In sharp contrast, the intact lFN8 promoter is efficiently induced by virus infection, but does not respond to any of the inducers that act on individual sites (Figure 1 ). In fact, the level of induction observed with the intact enhancer is at least an order of magnitude higher than that seen with any of the synthetic enhancers (Figure 1 ) (see also Leblanc et al., 1990) . Thus, the specific combination and arrangement of regulatory elements in the lFNf3 enhancer allow a highly specific response to virus induction and lead to a high level of induction.
This point was further illustrated by replacement of the PRDIV element with PRDII in the context of an otherwise intact lFN8 promoter (Figure 2A ). The resulting construct was transfected into HeLacells, and the activity was examined after stimulation with virus, TNFa, IFNT, or TNFa plus IFN?. As shown in Figure 2A , a 95-fold induction was observed with the wild-type lFN8 promoter, and this promoter did not respond toTNFa, IFNy, or the combination of these cytokines. Remarkably, the replacement of PRDIV with PRDIC not only resulted in a decrease in the level of virus induction, but the altered promoter was equally responsive to TNFa (Figure 2A) . Interestingly, the combined treatment with IFNy and TNFa revealed weak synergistic interactions between PRDII and PRDI-III, which are not evident in the wild-type promoter ( Figure 2A ). We conclude that the highly specific activation of the lFN6 gene in response to virus infection is a consequence of the unique arrangement and collection of transcription factor-binding sites.
Virus Induction of the IFNp Gene Enhancer Requires Specific Helical Phasing of Individual Transcription Factor-Binding Sites A striking characteristic of the lFN8 gene enhancer is the close spacing of individual regulatory elements. Virtually every base pair of the promoter contacts a regulatory protein, and every nucleotide is required for maximal levels of virus induction. Thus, if protein-protein interactions between the activators bound to these elements are essential for enhancer function, altering the relative positions of these elements on the DNA double helix should adversely affect enhancer function. We therefore constructed lFN8 promoters in which a half-or full-helical turn of DNA was inserted between individual PRDs. To avoid the generation of fortuitous binding sites for transcriptional activators or repressors, we randomized the inserted DNA sequence. Four different isolates with different insertion sequences were selected, linked to the bacterial chloramphenicol acetyltransferase (CAT) gene, and used in transfection experiments.
Human HeLa cells were transiently transfected with reporter genes bearing either the wild-type lFN8 promoter or promoters with insertion mutations. The level of CAT activity was determined from cell extracts derived from either mock-or Sendai virus-induced cells. Virus induction of the wild-type lFN8 promoter resulted in a 156-fold increase in CATactivity(Figure2B, line 1). However, when slightly more than a half-helical turn (6 bp) was introduced between PRDI and PRDII, the level of virus induction was only B-fold ( Figure 28 , line 2). Remarkably, insertion of 10 bp, which reestablishes the relative positions of binding sites on the face of the DNA helix, fully restored the activity of the promoter (Figure 28, line 3) . Similarly, insertion of 1992 , 1995b Du et al., 1993) . The only known candidate for activation from the PRDIII-I element is IRF-1 (Miyamoto et al., 1988) . However, the results of recent /RF-7 gene knockout studies have shown that IRF-1 is not essential for virus induction in vivo (Matsuyama et al., 1993; Reis et al., 1994) . Thus, either IRF-1 is not involved in lFNf3 gene regulation or another as yet unidentified factor can substitute functionally. In the absence of other factors capable of activating transcription from PRDIII-I, and given the demonstration that IRF-1 can interact and synergize with the ~50 subunit of NF-KB (Neish et al., 1995) , we have used IRF-1 to study the in vitro assembly of the lFNf3 gene enhanceosome.
The transcriptional synergy observed among individual regulatory elements of the lFN6 promoter may be due, at least in part, to cooperative binding of the corresponding transcription factors. To address this possibility, we carried out in vitro DNA binding experiments with purified recombinant proteins. The binding activity of each activator was determined separately in titration experiments (data not shown), and the appropriate amounts of protein were used in each experiment. Figure 3 shows that increasing amounts of recombinant IRF-1 protein protect the PRDI-III element from DNase I cleavage in a concentration-dependent manner (compare lane 1 with lanes 4-9). At the highest concentrations of IRF-1, protection is extended over PRDII and a portion of PRDIV (see also Fujita et al., 1988) In conjunction with other studies showing that HMG l(Y) binds specifically to the lFN/3 enhancer, that it promotes the binding of both NF-~6 and ATF-2 to their respective sites (Thanos and Maniatis, 1992; Du et al., 1993) , and that it alters the structure of the PRDII-NF-I& complex (Falvo et al., 1995) , our observations indicate that HMG l(Y) plays an essential role in the cooperative assembly of a multicomponent IFNP enhancer complex. Moreover, this role requires the correct helical phasing of transcription factor-binding sites.
Synergistic Activation of the IFNP Promoter in Cotransfection
Experiments Requires the Correct Helical Phasing and HMG l(Y) To determine whether the cooperative interactions between transcriptional activator proteins observed in vitro are reflected by synergistic interactions between these factors in vivo, we performed cotransfection experiments in mouse embryonal P19 cells. These cells were chosen because they lack endogenous IRF-1 and NF-KB (Harada et al., 1990; Thanos and Maniatis, 1995a) . The wild-type IFND reporter plasmid was cotransfected into these cells along with increasing amounts of expression vectors encoding each activator alone or a combination of all three activators. Previous studies have shown that NF-KB and IRF-1 synergistically activate the IFNP gene promoter in cotransfection experiments (Garoufalis et al., 1994; Neish et al., 1995) . As shown in Figure 5A , increasing amounts of transfected NF-KB (lanes 2-5), IRF-1 (6-9), and ATF-2/ c-Jun (1 O-l 3) weakly activated transcription. In sharp contrast, cotransfection of the combination of the expression vectors encoding NF-KB, IRF-1, and ATF-2/c-Jun led to a synergistic activation of the IFND enhancer ( Figure 5A , lanes 14-17). For example, transfection of 100 ng of NF-KB ( Figure 5A , lane 2), IRF-1 (lane 6), or ATF9/c-Jun (lane 10) did not stimulate transcription from the intact IFNP promoter. However, when the same amounts of the activator expression constructs were cotransfected into the cells, a 47-fold stimulation of transcription was observed ( Figure 5A, lane 14) . More important, when even smaller amounts of expression vectors were cotransfected (amounts at which virtually no activation was observed with each activator alone), a high level of synergy was still observed ( Figure 5A, lanes 18-21) . These results are consistent with our in vitro binding experiments showing cooperative binding of the IFNP activators.
To determine whether the helical constraints that interfere with virus induction and in vitro binding also interfere with transcriptional synergy, we examined the effect of inserting DNA between PRDI and PRDII on the expression of the reporter gene in P19 cells. As shown in Figure 58 , cotransfection of the IFNP gene activators led to an additive activation, as opposed to the synergistic activation was performed as in (A), except that the probe contained 6 bp inserted between PRDI and PRDII. The amounts of recombinant proteins used were as in Figure 3 . Mouse embryonal PI9 cells were cotransfected with the wild-type lFNj3 reporter plasmid (A) or the helical mutated reporter (B), along with increasing amounts of expression vectors directing the synthesis of p50 plus ~65, ATF-2 plus c-Jun, and IRF-1. Lane I, 9 pg of empty expression vector. Lanes 2-5, increasing amounts of an equimolar mixture of p50 and ~65 expression plasmids (100 ng, 300 ng, 1 pg, and 3 pg). Lanes 6-9, increasing amounts of /RF-7 expression plasmid (100 ng, 300 ng, 1 pg. and 3 r(g). Lanes 10-13, increasing amounts of an equimolar mixture of ATF-2 and c-jun expression plasmids (100 ng, 300 ng, 1 pg. and 3 pg). Lanes 14-17, increasing amounts (100 ng, 300 ng, 1 pg, and 3 pg) of all the expression vectors.
Lanes 18-21, increasing amounts (3 ng, IO ng, 30 ng, and 100 ng) of all the expression vectors (A). No synergisticactivation isobserved with the helical mutated IFNP promoter (6). The relative CAT activities for lanes l-21 in (A) are: 1, 1.3, 2, 4, 9, 1, 2, 12, 28, 1, 1.5, 3, 5, 47, 135, 256, 540, 2, 5, 40, and 157 . The relative CAT activities for lanes I-17 in (B) are: I, I, 2, 2.4, 12, I, 1.5, 6, 21, I, 1.8, 2, 12, 2, 3, 14, and 67. ing has been previously described (Carey et al., 1990 Drosophila SL2 cells were transfected with the reporter construct containing the lFN6 wild-type (lanes 1-9) or the helical mutant promoters (lanes 10-18) along with the indicated Drosophila expression vectors. The cells were harvested 48 hr after transfection. and the CAT activity was determined.
Lanes 1 and 10, 8 ug of empty expression vector; lanes 2 and 11, 1 ng of an equimolar mixture of ~50. and p65-expressing plasmids; lanes 3 and 12, 1 ug of /RF-1 expression vector; lanes 4 and 13,l pg of an equimolar mixture of A TF-2 and c-jun expression vectors; lanes 5 and 14, 2 ug of HMG I expression vector. Lanes 6 and 15 received the indicated expression plasmids in the same amounts as lanes 2-5 and 11-14. Lanes 7-9 and 16-18 received the same amount of activators as in lanes 6 and 15. plus increasing amounts of HMG l-expressing plasmid (1, 2, and 4 pg).
The human lFNf3 gene is specifically activated in response to virus infection. Here, we provide evidence showing that this process requires the assembly of an enhanceosome, a higher order nucleoprotein complex containing at least three types of transcription factors and HMG l(Y). First, we show that a specific type and number of transcription factor-binding sites and their correct positioning on the face of the DNA double helix are required for virus induction, synergistic activation by transfected transcriptional activators, and the correct assembly of an enhancer complex in vitro. It is important to note that enhancers inactivated by the insertion of a half-helical turn can be fully reactivated by the addition of a second half-helical turn, which reestablishes the normal helical phasing of transcription factor-binding sites. Second, we show that HMG l(Y) is required for the synergistic interactions between transcriptional activators in cotransfection experiments in vivo and for cooperative interactions in enhanceosome assembly in vitro. Strikingly, these functions of HMG l(Y) also depend on a specific arrangement of protein-binding sites on duplex DNA.
Multiple protein-protein and protein-DNA interactions, and the formation of a highly specific three-dimensional structure, provide a self-editing mechanism for ensuring that the lFNf3 gene is activated by virus and not by the many inducers of NF-KB or of the other transcriptional activators that bind to the enhancer. In addition, the cooperativity of enhanceosome assembly could determine the threshold levels of transcription factors required for transcriptional activation, and these levels could be inducer specific.
According to the model of enhanceosome structure illustrated in Figure 8 , enhanceosome assembly would require the coordinate induction of all the lFNf3 gene activators and the presence of HMG l(Y). In addition, specific members of each transcription factor family would be selected for assembly. For example, the PRDII and the PRDIV elements are recognized by a number of different Rel and bZlP protein family members, respectively. However, a number of observations indicate that the p5O/p65 heterodimer is the optimal Rel family member involved in the activation of the lFNf3 gene (Thanos and Maniatis, 1995a) . Similarly, the only proteins detected in virusinducible gel shifts of PRDIV are ATF-2 homodimers and ATF-2/c-Jun heterodimers (Du et al., 1993) . The JunDFosB heterodimer is capable of binding to PRDIV in vitro, but this interaction is strongly inhibited by HMG l(Y) (Du et al., 1993 for activation via PRDI and PRDIII has not been definitively identified. For the purpose of discussion here, however, IRF-1 is capable of promoting enhanceosome assembly in vitro and synergistic interactions in vivo. The formation of transcription factor complexes consisting of specific members of different families of transcription factors could, therefore, provide the meansof integrating multiple signaling pathways to target the activation of specific genes.
An essential feature of the model outlined in Figure 8 is the role of HMG l(Y) (Thanos and Mania& 1992; Du et al., 1993) . HMG l(Y) binds to the indicated sites in vitro and stimulates the binding of both NF-KB and ATF9/c-Jun to their respective binding sites. An additional HMG I(Y)-binding site was recently identified between the NF-KB site and the TATA box, and mutations in this site also interfere with HMG l(Y) binding and significantly decrease the level of virus induction (D. T. and T. M., unpublished data). In an accompanying paper, we examine the structural role of HMG l(Y) in the IFNfl gene enhanceosome (Falvo et al., 1995) . We show that PRDII has an intrinsic bend, which is reversed in a dimer-specific fashion by NF-KB in conjunction with HMG l(Y). The reversal of this bend correlates with the cooperative binding of NF-KB and HMG l(Y) to PRDII and with the ability of NF-KB to mediate virus induction of the IFNP enhancer. We also show that PRDIV is intrinsically bent and that this bend is reversed by the binding of ATF-2/c-Jun. The DNA conformation in this complex is further modulated by HMG l(Y) (Falvo et al., 1995) . Thus, the IFNB enhancer appears to be prebent in an inactive configuration, and enhanceosome assembly leads to conformational changes required for the formation of an active complex.
The multiple protein-protein interactions portrayed in the model of Figure 8 are also supported by the ObSeNations that NF-KB and ATF9/c-Jun (Du et al., 1993; Kaszubska et al., 1993 ; data not shown) and IRF-1 and NF-KB (Neish et al., 1995) interact specifically in solution in the absenceof DNA. The fact that interactions between NF-KB and ATF-2 are stimulated by HMG l(Y) (data not shown) is not reflected in the model, since the mechanism of this stimulation is not known. The role of specific protein-protein interactions between HMG l(Y) and ATF-2 and between NF-KB and ATF-2 was directly demonstrated in vivo by the inability of the ATF-2192 variant (which does not interact with HMG l(Y) or NF-KB) to support synergistic activation of the IFNB promoter at lower levels of ATF-2 expression.
Generality of Enhanceosomes
Previous studies have shown that alterations in the relative positions of upstream activator-binding sites and core promoters can adversely affect the activity of some prokaryotic (reviewed by Perez-Martin et al., 1994) and eukaryotic promoters (Windle and Sollner-Webb, 1986; Xie and Rothblum, 1992; Takahashi et al., 1986; Wu and Berk, 1988) . However, in early studies, alterations in the helical relationships and relative orientations of transcription factorbinding sites within eukaryotic enhancers (Fromenthal et al., 1988; Ondek et al., 1988) and promoters (McKnight, 1982) did not significantly affect transcription. In addition, multiple copies of transcription factor-binding sites can mimic the properties of the intact enhancers and promoters from which they were derived (McKnight and Yamamote, 1992) . Thus, higher order structures were not thought to be essential for enhancer and promoter function.
More recent studies, however, have shown that changes in the relative positions of transcription factorbinding sites within enhancers and promoters can interfere with transcription (Natesan and Gilman, 1993; Giese et al., 1995; Meacocket al., 1994; Reithetal., 1994) . Moreover, proteins that alter DNA structure play an essential role in enhancer function (Natesan and Gilman, 1993; Giese et al., 1992 Giese et al., , 1995 Giese and Grosschedl, 1993 ; for recent review see Grosschedi, 1995) and lead to either activation or repression. These individual cases show the general importance of higher order structure in enhancer function, but they differ significantly from the IFN(3 gene. First, the IFNP enhancer contains multiple HMG I(Y)-binding sites, while the other enhancers contain a single binding site for an architectural protein. Second, HMG l(Y) interacts specifically with all three of the transcriptional activators that bind to the IFN(3 enhancer. Third, HMG l(Y) does not induce a sharp DNA bend when it binds to the IFNP enhancer. Rather, HMG l(Y) facilitates the reversal of intrinsic DNA bends in PRDII and PRDIV (Falvo et al., 1995) .
A helical phasing requirement has also been demonstrated for TNFa induction of the E-selectin promoter (Meacock et al., 1994) , a promoter which has been shown tocontain HMG I(Y)-bindingsites (Lewisetal., 1994; Whitley et al., 1994) . Mutations in at least one of these sites, which abolish HMG l(Y) binding, also adversely affect TNFa induction (Lewis et al., 1994; Whitley et al., 1994) . It is important to note, however, that strict spatial requirements for transcription factor-binding sites are not a property shared by all enhancers. For example, enhancer elements can be distributed over many thousands of base pairs of DNA (Goto et al., 1989; Corbin and Maniatis, 1990) and enhancers containing distinct organizations of the same binding sites can mediate expression in the Drosophila neuroectoderm (Gonzalez-Crespo and Levine, 1994) . In fact, the requirements for spatial organization of a specific set of enhancer elements can be germ layerspecific during embryogenesis (Szymanski and Levine, 1995) . Thus, enhancers can display considerable flexibility in their organization, perhaps a reflection of the mechanisms involved in the creation of novel patterns of gene expression during evolution. On the other hand, enhancers required for inducible on/off switches that respond to distinct extracellular signals may have evolved special mechanisms for achieving a high level of specificity.
Experimental Procedures
Cell Culture and Transfections HeLa or PI9 cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, antibiotics, and L-glutamine (2 mM) in a humidified incubator containing 5% CO,. Transient transfections, virus inductions, and CAT assays were performed essentially asdescribed previously (Thanos and Maniatis, 1992) . HeLa cells were transfected with 12 pg of reporter plasmid, 3 ng of CMV-S-gal expression vector, and 5 ag of pSP73 carrier plasmid. CAT activity was normalized for transfection efficiency by f%galactosidase activity (Miller, 1972) . P19 cells were plated in 6-well plates 1 day prior to transfection and were approximately 30% confluent at the time of transfection.
The cells were refed with fresh media 3 hr before transfechon. The transfection cocktail contained 1 ng of reporter plasmid, 100 ng of CMV+gal, and the indicated amounts of expression vectors. The total amount of DNA was kept constant by including the appropriate amounts of the empty expression vector. Inductions with Sendai virus, TNFa, IFNy. and CAMP were performed as previously described (Fan and Maniatis. 1989; Du et al., 1993; Thanos and Maniatis, 1995a) . Drosophila melanogaster SL2 cells were maintained in Schneider media (GIBCO BRL) and supplemented with 12% fetal calf serum and antibiotics at ambient temperature. SL2 cells were plated in 6-well dishes 24 hr prior to transfection and transfected by the method of Chen and Okayama (1988) . Cells were harvested 48 hr posttransfection, and CAT activity was determined from cell extracts. Normalization for transfection efficiency was performed in all experiments based on b-galactosidase activity. The transfection cocktail contained 1 ag of the -1 lOIFNf3-CAT reporter construct, 100 ng of hsp82lacZ plasmid (which was used as an internal control for transfection efficiency) (Abel et al., 1992) and the indicated activators.
Vector DNA (pPAC) was added as necessary to achieve a constant amount of transfected DNA.
Plasmid Constructions Insertion and substitution mutants of the IFNS promoter were constructed by using the PCR methodology described previously (Thanos and Maniatis, 1992) and all mutations were verified by DNA sequencing. The PRDIV to PRDII substitution was constructed by replacing the ATF-2lcJun binding site (-100 to -91) with PRDII (-64 to -55). The I/II6 and l/Ill0 constructs contain insertions between nucleotides -65 and -64 from the start site of transcription.
The IV/Ill4 and IV/ III10 constructs have insertions between -91 and -90. Finally, the II/ TATAG and ll/TATAlO contain insertions between -38 and -37. The mammalian expression vectors for ~50, ~65, ATF-2, cJun, and IRF-1 were as previously described ( 1992; Du et al., 1993) . To construct the /RF-I expression plasmid. the entire open reading frame of /RF-7 was cloned in the bacterial expression vector pRSETA (Invitrogen) in-frame with the His-6 moiety. After refoldmg, the proteins were concentrated
(1 mglml, except p5O/p65. which was 300 nglml) and extensively dialyzed in DB buffer without BSA but supplemented with 0.3% NP-40 and 0.5 mM PMSF. For the DNase I footprinting experiments, IFNp promoter fragments (20,000 cpm) from -110 to f20 were end labeled at the noncoding strand and incubated with the indicated proteins in 20 ul of DB buffer (10 mM Tris [pH 8.0) 15 mM HEPES [pH 7.91 , 50 mM NaCI, 5 mM MgCI,, I mM d?T) and 1 mglml BSA, 5% glycerol on ice for 30 min. DNase I (Worthington) was diluted in 50 mM CaCl*, 20 mM HEPES (pH 7.9) to.2 nglmlyand 2 I*I was added directly to the binding reaction. Digestion was allowed for 5 min on ice, followed by the addition of 200 PI of stop buffer (2.5 M ammonium acetate, 25 uglml sonicated salmon sperm DNA). The DNAwas ethanol-precipitated, dried, resuspended in 3 nl of formamide dye, and loaded on a 6% sequencing gel.
